Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Hopewell Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Hopewell Therapeutics

Hopewell Therapeutics

Seed

Hopewell Therapeutics: Leading in innovative, nanoparticle-based drug delivery solutions.

HQ
Woburn, MA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Hopewell Therapeutics focuses on pioneering nanoparticle-based drug delivery solutions, particularly using lipid-based nanoparticles. Their mission is to revolutionize the pharmaceutical industry by enhancing the efficacy and safety of drug delivery systems. They cater to the healthcare and biotechnology markets, aiming to provide advanced therapeutic options.

The company has achieved significant advancements in drug delivery technology, contributing to improved patient outcomes. Their innovative approach has positioned them as a leader in the field, impacting the way drugs are administered and absorbed in the body.

Hopewell Therapeutics - Similar Companies

Advanced NanoTherapies logo

Advanced NanoTherapies

Enable Therapeutics logo

Enable Therapeutics

Cello Therapeutics logo

Cello Therapeutics

cellothera.com

NMB Therapeutics logo

NMB Therapeutics

Optimeos Life Sciences logo

Optimeos Life Sciences

optimeos.com

Nanotransfer logo

Nanotransfer

nanotransfer.bio

Lattice Therapeutics logo

Lattice Therapeutics

SpringLeaf Therapeutics logo

SpringLeaf Therapeutics

NanoPharmaceuticals logo

NanoPharmaceuticals

NeuroHope Therapeutics logo

NeuroHope Therapeutics

POP Biotechnologies logo

POP Biotechnologies

Aera Therapeutics logo

Aera Therapeutics

aeratx.com

Nano RED logo

Nano RED

Souvie Biodelivery logo

Souvie Biodelivery

Cytonus Therapeutics logo

Cytonus Therapeutics

cytonus.com

Hopewell Therapeutics - Quick Facts

Who are Hopewell Therapeutics' competitors?

Companies similar to Hopewell Therapeutics include Advanced NanoTherapies, Enable Therapeutics, Cello Therapeutics and NMB Therapeutics.

When was Hopewell Therapeutics founded?

Hopewell Therapeutics was founded in 2018.

Where is Hopewell Therapeutics' headquarters located?

Hopewell Therapeutics' headquarters is located in Woburn, MA, US.

When was Hopewell Therapeutics' last funding round?

Hopewell Therapeutics' most recent funding round was for $25M (USD) in June 2023.

How much has Hopewell Therapeutics raised to-date?

As of Jun 2, 2023, Hopewell Therapeutics has raised a total of $40.1M (USD).

How many employees does Hopewell Therapeutics have?

Hopewell Therapeutics has 17 employees as of Feb 5, 2024.

Hopewell Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Nanotechnology
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Delivery
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified